Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The SURMOUNT clinical trial program, which evaluated tirzepatide for weight management, showed improvements in multiple cardiometabolic risk factors, including lipid parameters
Hendricks EJ et al
Even though Part D enrollment is required, the Bridge program itself works differently
The results showed that patients receiving exenatide experienced a positive effect
US$ 27.03
US$ 22.55
US$ 23.41
US$ 24.08
US$ 29.58
US$ 27.93
